Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
Alaunos Therapeutics, Inc. (ZIOP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/07/2021 |
GN
| Ziopharm Oncology to Present Poster at American Association for Cancer Research Virtual 2021 Annual Meeting |
| 02/05/2021 |
GN
| Ziopharm Oncology Announces Election of Robert Postma to its Board of Directors |
| 12/23/2020 |
GN
| Ziopharm to Participate in Upcoming January Conferences |
| 12/21/2020 |
GN
| Ziopharm Oncology Announces Clearance of Taiwan's First IND of Non-viral CAR-T for the Treatment of Relapsed CD19+ Leukemias and Lymphomas |
| 12/16/2020 |
GN
| Ziopharm Comments on Consent Solicitation Results |
| 12/14/2020 |
GN
| Ziopharm Oncology Announces Chief Financial Officer to Step Down |
| 12/11/2020 |
GN
| Ziopharm Comments on Delay of WaterMill's Stated Consent Deadline |
| 12/10/2020 |
GN
| Egan-Jones Recommends Against Electing Dissident's Full Slate of Nominees to Ziopharm Board |
| 12/04/2020 |
GN
| Ziopharm Details Actions in Response to Shareholder Feedback |
| 11/27/2020 |
GN
| Ziopharm Comments on Institutional Shareholder Services' Recommendation to Reject WaterMill's Attempt to Remove Half of Ziopharm's Board of Directors |
| 11/20/2020 |
GN
| Ziopharm Releases Investor Presentation Highlighting Execution of Strategy and Substantial Board Refreshment to Enhance Shareholder Value |
| 11/19/2020 |
GN
| Ziopharm Oncology Presents Encouraging Clinical Data for Controlled IL-12 for the Treatment of Glioblastoma and DIPG at the 2020 Society for Neuro-Oncology Annual Meeting |
| 11/17/2020 |
GN
| Ziopharm Oncology Appoints Raffaele Baffa, M.D., Ph.D., as Chief Medical Officer |
| 11/16/2020 |
GN
| Ziopharm Oncology Appoints Mary Thistle to Board of Directors |
| 11/13/2020 |
GN
| Ziopharm Oncology to Participate in Jefferies Virtual London Healthcare Conference on November 19, 2020 |
| 11/02/2020 |
GN
| Ziopharm Files Definitive Consent Revocation Statement and Sends Letter to Shareholders |
| 09/22/2020 |
GN
| Ziopharm Oncology Appoints Kevin Buchi to its Board of Directors |
| 09/14/2020 |
GN
| Ziopharm Oncology Granted Rare Pediatric Disease Designation for Controlled IL-12 for the Treatment of DIPG |
| 08/06/2020 |
GN
| Ziopharm Oncology Reports Second Quarter 2020 Financial Results and Provides Corporate Update |
| 07/28/2020 |
GN
| Ziopharm Oncology to Report Second Quarter 2020 Financial Results and Host a Conference Call and Webcast on August 6, 2020 |
| 07/22/2020 |
GN
| Ziopharm Oncology Names James Huang to Board of Directors |
| 06/15/2020 |
GN
| Ziopharm Oncology Appoints Carl June, M.D., as Chairman of Scientific Advisory Board |
| 06/12/2020 |
GN
| Ziopharm Oncology to Participate in Cell Therapy Panel at the Raymond James Human Healthcare Innovation Conference on June 17, 2020 |
| 05/27/2020 |
GN
| Ziopharm Oncology Announces Management Transition |
| 05/27/2020 |
GN
| Ziopharm Oncology to Present at the Jefferies 2020 Healthcare Conference on June 3, 2020 |
| 05/08/2020 |
GN
| Ziopharm Oncology to Present at the BofA Securities 2020 Health Care Conference |
| 04/27/2020 |
GN
| Ziopharm Oncology to Report First Quarter 2020 Financial Results and Host a Conference Call and Webcast on May 7, 2020 |
| 03/02/2020 |
GN
| Ziopharm Oncology Reports Financial Results for Fourth Quarter and Full Year 2019 |
| 02/24/2020 |
GN
| Ziopharm Oncology to Host Conference Call to Discuss Fourth Quarter and Full Year 2019 Results on March 2, 2020 |
| 01/30/2020 |
GN
| Ziopharm Oncology Announces Recent Publications in Peer-Reviewed Scientific Journals |
| 12/09/2019 |
GN
| Ziopharm Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) |
| 12/08/2019 |
GN
| Ziopharm Oncology Presents Pre-Clinical Data Validating “Rapid Personalized Manufacture” (RPM) with TCR at the 2019 American Society for Hematology Annual Meeting |
| 11/23/2019 |
GN
| Ziopharm Oncology Presents Encouraging Clinical Data for Controlled IL-12 for the Treatment of Recurrent Glioblastoma at the 2019 Society for Neuro-Oncology Annual Meeting |
| 11/18/2019 |
GN
| Ziopharm Oncology Updates Presentation and Webcast Time at the Jefferies 2019 London Healthcare Conference |
|
|
|